The human immunodeficiency virus-1 genotype diversity and drug resistance mutations profile of volunteer blood donors from Chinese blood centers

Transfusion

Volumn 52, Issue 5, 2012, Pages 1041-1049

  Zeng, Peibin ^{a,b,c,d,e,f,g,h,i}   Wang, Jingxing ^{a,b,c,d,e,f,g,h,i}   Huang, Yi ^{a,b,c,d,e,f,g,h,i}   Guo, Xiaoming ^{a,b,c,d,e,f,g,h,i}   Li, Julin ^{a,b,c,d,e,f,g,h,i}   Wen, Guoxin ^{a,b,c,d,e,f,g,h,i}   Yang, Tonghan ^{a,b,c,d,e,f,g,h,i}   Yun, Zhongqiao ^{a,b,c,d,e,f,g,h,i}   He, Miao ^{a,b,c,d,e,f,g,h,i}   Liu, Yu ^{a,b,c,d,e,f,g,h,i}   Yuan, Yuzhe ^{a,b,c,d,e,f,g,h,i}   Schulmann, Jane ^{a,b,c,d,e,f,g,h,i}   Glynn, Simone ^{a,b,c,d,e,f,g,h,i}   Ness, Paul ^{a,b,c,d,e,f,g,h,i}   Jackson, J Brooks ^{a,b,c,d,e,f,g,h,i}   Shan, Hua ^{a,b,c,d,e,f,g,h,i}  

^a INSTITUTE OF BLOOD TRANSFUSION   (China)

^b Mianyang Blood Center   (China)

^c Guangxi Blood Center   (China)

^d Urumqi City Blood Center   (China)

^e Yunnan Kunming Blood Center   (China)

^f Luoyang Blood Center   (China)

^g WESTAT   (United States)

^h NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

ⁱ JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE;

ADULT; ARTICLE; BLOOD BANK; BLOOD DONOR; BLOOD SAMPLING; CHINESE; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; STRUCTURAL GENE; VIRUS RESISTANCE;

ADULT; AGED; BLOOD DONORS; CHINA; DRUG RESISTANCE, VIRAL; FEMALE; GENETIC VARIATION; GENOTYPE; HIV-1; HUMANS; MALE; MIDDLE AGED; MUTATION;

EID: 84861102145     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03415.x     Document Type: Article

References (50)

1. UNAIDS. UNAIDS report on the global AIDS epidemic. 2010. [cited 2011 Jan 13]. Available from: URL http://www.unaids.org/en/Regionscountries/Countries/ China/
2. China Ministry of Public Health: News Press. Overview of the national notifiable infectious diseases. 2010. [cited 2011 Feb 10]. Available from: URL http://www.moh.gov.cn
3. Hemelaar J, Gouws E, Ghys PD, Osmanov S. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 2006;20:W13-23.
4. Los Alamos National Laboratory. Los Alamos National Laboratory database. 2010. [cited 2010 Jan]. Available from: URL http://www.hiv.lanl.gov
5. Shang H, Han X, Shi X, Zuo T, Goldin M, Chen D, Han B, Sun W, Wu H, Wang X, Zhang L,. Genetic and neutralization sensitivity of diverse HIV-1 env clones from chronically infected patients in China. J Biol Chem 2011; 286: 14531-41.
6. Hemelaar J, Gouws E, Ghys PD, Osmanov S,. Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS 2011; 25: 679-89.
7. Zhang Y, Lu L, Ba L, Liu L, Yang L, Jia M, Wang H, Fang Q, Shi Y, Yan W, Chang G, Zhang L, Ho DD, Chen Z,. Dominance of HIV-1 subtype CRF01-AE in sexually acquired cases leads to a new epidemic in Yunnan province of China. PLoS Med 2006; 3: e443.
8. Tee KK, Pybus OG, Li XJ, Han X, Shang H, Kamarulzaman A, Takebe Y,. Temporal and spatial dynamics of human immunodeficiency virus type 1 circulating recombinant forms 08-BC and 07-BC in Asia. J Virol 2008; 82: 9206-15.
9. Tee KK, Pybus OG, Liao H, Uenishi R, Hase S, Kamarulzaman A, Li XJ, Takebe Y,. Chronology of the HIV-1 CRF07-BC expansion in East Asia. AIDS 2008; 22: 156-8.
10. Li L, Liang S, Chen L, Liu W, Li H, Liu Y, Bao Z, Wang Z, Zhuang D, Liu S, Li J,. Genetic characterization of 13 subtype CRF01-AE near full-length genomes in Guangxi, China. AIDS Res Hum Retroviruses 2010; 26: 699-704.
11. Xu Y, Qiu Q, Li Y, Chu C, Wu W, Qiu H,. The study about HIV-1 subtypes among sexually transmitted HIV-1 cases in Kunming. Modern Prev Med (Chin) 2008; 35: 4668-76.
12. Ma L, Huang J, Xing H, Yuan L, Yu X, Sun J, Huang Y, Qu S, Feng Y, Liao L, Liu S, Shao Y,. Genotypic and phenotypic cross-drug resistance of harboring drug-resistant HIV type 1 subtype B' strains from former blood donors in central Chinese provinces. AIDS Res Hum Retroviruses 2010; 26: 1007-13.
13. Cui WG, Xin H, Wang Z, Huang HL, Li H, Ma PF, Xue XL, Wei M, Zhu XP, Shao YM,. Study on subtype and sequence of the C2-V3 region of env gene among HIV-1 strains in Henan province. China J AIDS/STD (Chin) 2004; 10: 403-6.
14. Richman DD,. HIV chemotherapy. Nature 2001; 410: 995-1001.
15. Perrin L, Telenti A,. HIV treatment failure: testing for HIV resistance in clinical practice. Science 1998; 280: 1871-3.
16. Caride E, Hertogs K, Larder B, Dehertogh P, Brindeiro R, Machado E, de Sa CA, Eyer-Silva WA, Sion FS, Passioni LF, Menezes JA, Calazans AR, Tanuri A,. Genotypic and phenotypic evidence of different drug-resistance mutation patterns between B and non-B subtype isolates of human immunodeficiency virus type 1 found in Brazilian patients failing HAART. Virus Genes 2001; 23: 193-202.
17. Little SJ, Frost SD, Wong JK, Smith DM, Pond SL, Ignacio CC, Parkin NT, Petropoulos CJ, Richman DD,. Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection. J Virol 2008; 82: 5510-8.
18. Chin BS, Choi JY, Han Y, Kuang J, Li Y, Han SH, Choi H, Chae YT, Jin SJ, Baek JH, Lim YS, Kim CO, Song YG, Yong D, Li T, Kim JM,. Comparison of genotypic resistance mutations in treatment-naive HIV type 1-infected patients in Korea and China. AIDS Res Hum Retroviruses 2010; 26: 217-21.
19. Balode D, Westman M, Kolupajeva T, Rozentale B, Albert J,. Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia. J Med Virol 2010; 82: 2013-8.
20. Jiang S, Xing H, Si X, Wang Y, Shao Y,. Polymorphism of the protease and reverse transcriptase and drug resistance mutation patterns of HIV-1 subtype B prevailing in China. J Acquir Immune Defic Syndr 2006; 42: 512-4.
21. Li J, Lu JF, Dong HH, Bao ZY, Liu SY, Li HP, Zhuang DM, Liu YJ, Li H, Wang Z, Wu H, Li JY,. Phenotypic resistance of resistant strains of HIV type-1 subtype B in China. Chin Med J (Engl) 2006; 119: 1972-7.
22. Yam WC, Chen JH, Wong KH, Chan K, Cheng VC, Lam HY, Lee SS, Zheng BJ, Yuen KY,. Clinical utility of genotyping resistance test on determining the mutation patterns in HIV-1 CRF01-AE and subtype B patients receiving antiretroviral therapy in Hong Kong. J Clin Virol 2006; 35: 454-7.
23. Han X, Zhang M, Dai D, Wang Y, Zhang Z, Liu J, Geng W, Jiang Y, Takebe Y, Shang H,. Genotypic resistance mutations to antiretroviral drugs in treatment-naive HIV/AIDS patients living in Liaoning Province, China: baseline prevalence and subtype-specific difference. AIDS Res Hum Retroviruses 2007; 23: 357-64.
24. Liao L, Xing H, Li X, Ruan Y, Zhang Y, Qin G, Shao Y,. Genotypic analysis of the protease and reverse transcriptase of HIV type 1 isolates from recently infected injecting drug users in western China. AIDS Res Hum Retroviruses 2007; 23: 1062-5.
25. Zhong P, Pan Q, Ning Z, Xue Y, Gong J, Zhen X, Zhou L, Sheng F, Zhang W, Gai J, Cheng H, Yue Q, Xing H, Zhuang M, Lu W, Shao Y, Kang L,. Genetic diversity and drug resistance of human immunodeficiency virus type 1 (HIV-1) strains circulating in Shanghai. AIDS Res Hum Retroviruses 2007; 23: 847-56.
26. Ma L, Sun J, Xing H, Si X, Yuan L, Guo Y, Cheng H, Shao Y,. Genotype and phenotype patterns of drug-resistant HIV-1 subtype B' (Thai B) isolated from patients failing antiretroviral therapy in China. J Acquir Immune Defic Syndr 2007; 44: 14-9.
27. Tu YQ, Wang MJ, Yao J, Zhu XM, Pan PL, Xing WG, Zhang GH, Yang RG, Zheng YT, Jiang Y,. Human immunodeficiency virus-1 genotypic drug resistance among volunteer blood donors in Yunnan, China. Transfusion 2009; 49: 1865-73.
28. World Health Organization. Guidelines for surveillance of HIV drug resistance. 2003. [cited 2003 Oct]. Available from: URL http://wwwn.cdc.gov/dls/ ila/cd/who-afro/resisguide12-12.pdf
29. Tamura K, Dudley J, Nei M, Kumar S,. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007; 24: 1596-9.
30. Guo N, Wang J, Ness P, Yao F, Dong X, Bi X, Mei H, Li J, He W, Lu Y, Ma H, Wen X, Huang M, Wright DJ, King M, High P, Nelson K, Shan H,. Analysis of Chinese donors' return behavior. Transfusion 2011; 51: 523-30.
31. Zhang L, Chen Z, Cao Y, Yu J, Li G, Yu W, Yin N, Mei S, Li L, Balfe P, He T, Ba L, Zhang F, Lin HH, Yuen MF, Lai CL, Ho DD,. Molecular characterization of human immunodeficiency virus type 1 and hepatitis C virus in paid blood donors and injection drug users in china. J Virol 2004; 78: 13591-9.
32. China Ministry of Public Health: News Press. Estimated report of HIV/AIDS epidemic in China. 2009. [cited 2010 May 31]. Available from: URL: http://www.moh.gov.cn (in Chinese).
33. Yu G, Li Y, Li J, Diao L, Yan X, Lin P, He Q, Wang Y, Fu X, Yang F, Long Q,. Genetic diversity and drug resistance of HIV type 1 circulating recombinant Form-BC among drug users in Guangdong Province. AIDS Res Hum Retroviruses 2009; 25: 869-75.
34. Zhang J, Kang D, Fu J, Sun X, Lin B, Bi Z, Nkengasong JN, Yang C,. Surveillance of transmitted HIV type 1 drug resistance in newly diagnosed HIV type 1-infected patients in Shandong Province, China. AIDS Res Hum Retroviruses 2010; 26: 99-103.
35. Bao L, Vidal N, Fang H, Deng W, Chen S, Guo W, Qin C, Peeters M, Delaporte E, Andrieu JM, Lu W,. Molecular tracing of sexual HIV Type 1 transmission in the southwest border of China. AIDS Res Hum Retroviruses 2008; 24: 733-42.
36. Zhao F, Wang Z, Li WJ,. Human immunodeficiency virus type 1 subtypes prevalence in central China. Yonsei Med J 2009; 50: 644-9.
37. Xin R, He X, Xing H, Sun F, Ni M, Zhang Y, Meng Z, Feng Y, Liu S, Wei J, Shao Y,. Genetic and temporal dynamics of human immunodeficiency virus type 1 CRF07-BC in Xinjiang, China. J Gen Virol 2009; 90: 1757-61.
38. Liao H, Tee KK, Hase S, Uenishi R, Li XJ, Kusagawa S, Thang PH, Hien NT, Pybus OG, Takebe Y,. Phylodynamic analysis of the dissemination of HIV-1 CRF01-AE in Vietnam. Virology 2009; 391: 51-6.
39. Shan H, Wang JX, Ren FR, Zhang YZ, Zhao HY, Gao GJ, Ji Y, Ness PM,. Blood banking in China. Lancet 2002; 360: 1770-5.
40. Meade CS, Wang J, Lin X, Wu H, Poppen PJ,. Stress and coping in HIV-positive former plasma/blood donors in China: a test of cognitive appraisal theory. AIDS Behav 2010; 14: 328-38.
41. Wang L,. Overview of the HIV/AIDS epidemic, scientific research and government responses in China. AIDS 2007; 21 (Suppl 8): S3-7.
42. Liao L, Xing H, Shang H, Li J, Zhong P, Kang L, Cheng H, Si X, Jiang S, Li X, Shao Y,. The prevalence of transmitted antiretroviral drug resistance in treatment-naive HIV-infected individuals in China. J Acquir Immune Defic Syndr 2010; 53 (Suppl 1): S10-4.
43. DHHS. DHHS panel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. 2011. [cited 2011 Jan 10]. Available from: URL http://aidsinfo.nih. gov/Guidelines
44. Snoeck J, Kantor R, Shafer RW, Van Laethem K, Deforche K, Carvalho AP, Wynhoven B, Soares MA, Cane P, Clarke J, Pillay C, Sirivichayakul S, Ariyoshi K, Holguin A, Rudich H, Rodrigues R, Bouzas MB, Brun-Vezinet F, Reid C, Cahn P, Brigido LF, Grossman Z, Soriano V, Sugiura W, Phanuphak P, Morris L, Weber J, Pillay D, Tanuri A, Harrigan RP, Camacho R, Schapiro JM, Katzenstein D, Vandamme AM,. Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent. Antimicrob Agents Chemother 2006; 50: 694-701.
45. Beyrer C, Razak MH, Lisam K, Chen J, Lui W, Yu XF,. Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia. AIDS 2000; 14: 75-83.
46. Brennan CA, Stramer SL, Holzmayer V, Yamaguchi J, Foster GA, Notari Iv EP, Schochetman G, Devare SG,. Identification of human immunodeficiency virus type 1 non-B subtypes and antiretroviral drug-resistant strains in United States blood donors. Transfusion 2009; 49: 125-33.
47. Barreto CC, Nishyia A, Araujo LV, Ferreira JE, Busch MP, Sabino EC,. Trends in antiretroviral drug resistance and clade distributions among HIV-1-infected blood donors in Sao Paulo, Brazil. J Acquir Immune Defic Syndr 2006; 41: 338-41.
48. Transmission of drug-resistant HIV-1 in Europe remains limited to single classes. AIDS 2008; 22: 625-35.
49. Zhang X, Li S, Li X, Xu J, Li D, Ruan Y, Xing H, Shao Y,. Characterization of HIV-1 subtypes and viral antiretroviral drug resistance in men who have sex with men in Beijing, China. AIDS 2007; 21 (Suppl 8): S59-65.
50. Zhang F, Haberer JE, Wang Y, Zhao Y, Ma Y, Zhao D, Yu L, Goosby EP,. The Chinese free antiretroviral treatment program: challenges and responses. AIDS 2007; 21 (Suppl 8): S143-8.